ProShares - UltraShort Nasdaq Biotechnology
Limited financial coverage for BIS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.
- IPO
- 2010
- HQ
- Bethesda, MD, US
Price Chart
- Market Cap
- $2.48M
- Div Yield
- 6.01%
- 52W High
- $34.86
- 52W Low
- $12.72
- 50D MA
- $16.63
- 200D MA
- $19.05
- Beta
- -1.18
- Avg Volume
- 8.27K
Get TickerSpark's AI analysis on BIS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIS coverage
Recent articles, reports, and earnings notes.
No research on BIS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIS report →Similar companies
Peers in the same neighborhood.